Allvivo Vascular is a biomedical company focused on developing improved antimicrobial technologies to reduce medical device and wound-related infections. They collaborate with licensees and marketing partners to provide safe and effective treatment options that simplify infection control, enhance patient outcomes, and improve healthcare economics. Allvivo Vascular develops biomimetic coatings for medical devices, with lead products like Gatekeeper and ProteoGuard. Gatekeeper is a dual-function coating combining nonthrombogenic surface benefits with an active antibacterial agent, while ProteoGuard downregulates inflammatory responses and is highly thromboresistant, offering a promising alternative for preventing restenosis without the need for long-term dual antiplatelet therapy.